Skip to content

Hydromorphone hydrochloride combined with butorphanol for postoperative analgesia after video-assisted thoracoscopic surgery

Hydromorphone hydrochloride combined with butorphanol for postoperative analgesia after video-assisted thoracoscopic surgery: an exploratory clinical trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055649
Enrollment
Unknown
Registered
2022-01-15
Start date
2022-01-15
Completion date
Unknown
Last updated
2023-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

Group 1 :Hydromorphone hydrochloride combined with butorphanol
Group 2:Hydromorphone hydrochloride

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Elective patients undergoing thoracoscopic lobectomy/pulmonary wedge resection; 2. Age 18-65 years; 3. ASA I or II level; 4. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Previous history of opioid allergy; 2. Previous history of nausea and vomiting after general anesthesia and abnormal recovery from anesthesia; 3. Abnormal liver and kidney function before operation (alanine aminotransferase, aspartate aminotransferase, creatinine, and blood urea nitrogen exceed twice the normal value); 4. Those who cannot communicate normally with others, cannot understand VAS scores, and cannot use analgesic pumps (press when VAS scores >= 3); 5. Use sedatives, antiemetics, and antipruritic drugs within 24 hours before operation; 6. Long-term use of analgesics or antipsychotic drugs (including opioids, non-steroidal anti-inflammatory drugs, sedatives, antidepressants, etc.) due to chronic pain or mental and nervous system diseases; 7. Severe cardiopulmonary dysfunction.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale, VAS score;Richmond Agitation-Sedation Scale, RSAA;

Countries

China

Contacts

Public ContactJing Longnian

Beijing Tiantan Hospital, Capital Medical University

13146556349@163.com+86 13146556349

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026